239 related articles for article (PubMed ID: 17587829)
21. The phosphatase of regenerating liver 3 (PRL-3) promotes cell migration through Arf-activity-dependent stimulation of integrin α5 recycling.
Krndija D; Münzberg C; Maass U; Hafner M; Adler G; Kestler HA; Seufferlein T; Oswald F; von Wichert G
J Cell Sci; 2012 Aug; 125(Pt 16):3883-92. PubMed ID: 22595524
[TBL] [Abstract][Full Text] [Related]
22. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF
Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241
[TBL] [Abstract][Full Text] [Related]
23. An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells.
Wang L; Shen Y; Song R; Sun Y; Xu J; Xu Q
Mol Pharmacol; 2009 Dec; 76(6):1238-45. PubMed ID: 19779032
[TBL] [Abstract][Full Text] [Related]
24. Role of silencing phosphatase of regenerationg liver-3 expression by microRNA interference in the growth of gastric cancer.
Cai SR; Wang Z; Chen CQ; Wu WH; He YL; Zhan WH; Zhang CH; Cui J; Wu H
Chin Med J (Engl); 2008 Dec; 121(24):2534-8. PubMed ID: 19187591
[TBL] [Abstract][Full Text] [Related]
25. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
[TBL] [Abstract][Full Text] [Related]
26. PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo.
Guo K; Li J; Wang H; Osato M; Tang JP; Quah SY; Gan BQ; Zeng Q
Cancer Res; 2006 Oct; 66(19):9625-35. PubMed ID: 17018620
[TBL] [Abstract][Full Text] [Related]
27. Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.
Li J; Guo K; Koh VW; Tang JP; Gan BQ; Shi H; Li HX; Zeng Q
Clin Cancer Res; 2005 Mar; 11(6):2195-204. PubMed ID: 15788667
[TBL] [Abstract][Full Text] [Related]
28. The essential role of FKBP38 in regulating phosphatase of regenerating liver 3 (PRL-3) protein stability.
Choi MS; Min SH; Jung H; Lee JD; Lee TH; Lee HK; Yoo OJ
Biochem Biophys Res Commun; 2011 Mar; 406(2):305-9. PubMed ID: 21320469
[TBL] [Abstract][Full Text] [Related]
29. Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression.
Mizuuchi E; Semba S; Kodama Y; Yokozaki H
Int J Cancer; 2009 Apr; 124(8):1802-10. PubMed ID: 19115206
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of PRL-3 overexpression in early stages of colonic cancer.
Xing X; Peng L; Qu L; Ren T; Dong B; Su X; Shou C
Histopathology; 2009 Feb; 54(3):309-18. PubMed ID: 19236507
[TBL] [Abstract][Full Text] [Related]
31. Structure of human PRL-3, the phosphatase associated with cancer metastasis.
Kim KA; Song JS; Jee J; Sheen MR; Lee C; Lee TG; Ro S; Cho JM; Lee W; Yamazaki T; Jeon YH; Cheong C
FEBS Lett; 2004 May; 565(1-3):181-7. PubMed ID: 15135076
[TBL] [Abstract][Full Text] [Related]
32. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
33. 2-D Difference in gel electrophoresis combined with Pro-Q Diamond staining: a successful approach for the identification of kinase/phosphatase targets.
Orsatti L; Forte E; Tomei L; Caterino M; Pessi A; Talamo F
Electrophoresis; 2009 Jul; 30(14):2469-76. PubMed ID: 19639567
[TBL] [Abstract][Full Text] [Related]
34. The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation.
Basak S; Jacobs SB; Krieg AJ; Pathak N; Zeng Q; Kaldis P; Giaccia AJ; Attardi LD
Mol Cell; 2008 May; 30(3):303-14. PubMed ID: 18471976
[TBL] [Abstract][Full Text] [Related]
35. Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity.
Han YM; Lee SK; Jeong DG; Ryu SE; Han DC; Kim DK; Kwon BM
Bioorg Med Chem Lett; 2012 Jan; 22(1):323-6. PubMed ID: 22137788
[TBL] [Abstract][Full Text] [Related]
36. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.
Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H
Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563
[TBL] [Abstract][Full Text] [Related]
37. PRL-3 promotes the proliferation of LoVo cells via the upregulation of KCNN4 channels.
Lai W; Chen S; Wu H; Guan Y; Liu L; Zeng Y; Zhao H; Jiang J; Chu Z
Oncol Rep; 2011 Oct; 26(4):909-17. PubMed ID: 21725609
[TBL] [Abstract][Full Text] [Related]
38. PRL-3 activates NF-κB signaling pathway by interacting with RAP1.
Lian S; Meng L; Liu C; Xing X; Song Q; Dong B; Han Y; Yang Y; Peng L; Qu L; Shou C
Biochem Biophys Res Commun; 2013 Jan; 430(1):196-201. PubMed ID: 23178297
[TBL] [Abstract][Full Text] [Related]
39. miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer.
Zhang J; Xiao Z; Lai D; Sun J; He C; Chu Z; Ye H; Chen S; Wang J
Br J Cancer; 2012 Jul; 107(2):352-9. PubMed ID: 22677902
[TBL] [Abstract][Full Text] [Related]
40. [Phosphatase of regenerating liver-3 (PRL-3) and tumor metastasis].
Peng LR; Shou CC
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):1-3. PubMed ID: 17575683
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
